In this study we evaluated the effect of the competitive N-methyl-D-aspartate (NMDA) antagonist
D-(E) -4-(3 -p ho s ph onopro p-2-e n y I ) pipe raz i ne -2carboxylic acid (COP 40116) on both early (2 days) and late (28 days) ischemic brain damage in a rodent model of focal cerebral ischemia by means of magnetic resonance imaging (MRI) and conventional histology. Immediately after occlusion of the left middle cerebral artery (MCA), rats received either COP 40116 (20 mg/kg i.p.) or isotonic saline. Two MRI scans were performed in each animal 2 and 28 days after MCA occlusion. After the second scan, rats were perfusion fixed for histological evaluation. The volume of lesioned brain tissue as determined by MRI or histology was calculated from the damaged area in single sections and the distance between them. COP 40116 re duced acute infarct volume as measured by MRI 2 days The neuroprotective effect of N-methyl-o aspartate (NMDA) receptor antagonists in animal models of focal cerebral ischemia has been reported in a number of investigations (for review see Mc Culloch et aI., 1991; Sauer and Fagg, 1992) . How ever, in these studies brain damage has been rou tinely quantified only within a period of several hours up to 2 days after the induction of brain isch emia. Recently, two experiments have been re ported that examined the effect of the noncompet itive NMDA channel blocker dizocilpine (MK-801) on late histopathology following focal cerebral isch emia in rats or cats (Persson et aI., 1992; Dezsi et aI., 1994) . In both cases MK-801 did not reduce after MCA occlusion by 44% (p < 0.05, analysis of vari ance). After 28 days the lesion detected by MRI was still significantly smaller in the drug-treated animals. This finding was confirmed by the histological analysis show ing a 64% reduction in the volume of brain atrophy in the COP 40116 group (p < 0.05, analysis of variance). There was a good correlation between the MRI data and the results of the histological evaluation (r = 0.9). Our results indicate that (a) the competitive NMDA antagonist COP 40116 permanently protects brain tissue from the conse quences of cerebral ischemia in a rat model for human stroke and (b) early and late pathological changes can be accurately measured by MRI. Key Words: Brain atro phy-Cerebral ischemia-COP 40116-Magnetic reso nance imaging-N-Methyl-D-aspartate antagonist Permanent neuroprotection.
infarction quantified after a prolonged survival pe riod of 6 (Dezsi et aI., 1994) or 28 (Persson et aI., 1992) days. This suggests either that this NMDA antagonist may only delay the progression of isch emic brain damage or that a considerable part of the tissue showing acute ischemic damage in untreated animals may recover spontaneously. Since the ac tion of antagonists at the NMDA receptor complex on focal ischemic brain damage after prolonged re covery is of relevance with regard to the potential clinical use of such compounds, this study has been performed to further address this question.
We used the competitive NMDA receptor antag onist o-(E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (CGP 40116) (Fagg et aI., 1990) , which recently has been shown to reduce acute in farct volume in a rat model for human stroke with an efficacy comparable to MK-801 (Sauer et aI., 1993a) . Acute infarction was determined 2 d ays af ter middle cerebral artery (MCA) occlusion in rats by means of in vivo magnetic resonance imaging (MRI) (Allegrini and Sauer, 1992; Sauer et aI., 1993a ). Therefore, we were able to evaluate the late consequences of the ischemic insult in the same an imals after a total recovery period of 28 days using MRI and conventional histological methods. Since it has been reported that several weeks or months after MCA occlusion in rats, neuronal damage can also be detected in brain regions distant from the primary infarct (e.g., thalamus and substantia nigra) (Fujie et aI., 1990; Tamura et aI., 1990; Hara et aI., 1993) , we · also examined whether treatment with CGP 40116 influenced this phenomenon. Some re sults from this study have been published previ ously in abstract form (Sauer et aI., 1993b) .
MATERIAL AND METHODS

Induction of focal cerebral ischemia
Irreversible occlusion of the left MCA was performed in 22 male Fisher 344 rats (220-320 g; Iffa-Credo, France) as described previously (Tamura et aI., 1981; Sauer et aI., 1993a) . Briefly, animals were anesthetized with 2% isof lurane in a 70/30 (by vol) nitrous oxide/oxygen mixture, and with the use of an operating microscope (Wild AG, Heerbrugg, Switzerland), the left MCA was exposed by a subtemporal craniectomy beside the foramen ovale. After opening of the dura mater, the stem of the artery and its lenticulostriate branches were occluded by bipolar elec trocoagulation (Surgitron, Ellman, Hewlett, U.S.A.). Im mediately following the occlusion, animals received ei ther an intraperitoneal injection of 20 mg/kg CGP 40116 dissolved in isotonic saline (1 mllkg body wt; n = 11) or the same amount of vehicle (n = 11). Retracted soft tis sues were replaced, wounds were sutured, anesthesia was discontinued, and the rats were returned to their cages. Body temperature was maintained at 37"C by means of a rectal probe connected to a heating pad (CMA 115; Carnegie Medicine, Stockholm, Sweden) during sur gery and until animals regained consciousness.
MRI
Quantitative in vivo MRI measurements were per formed under light isoflurane (1-1.5%) anesthesia on a 4.7 -T 30-cm bore Spectrospin Biospec Spectrometer (Bruker, Karlsruhe, Germany) equipped with a 15-cm gradient coil. Each rat underwent two imaging cycles on days 2 and 28 after MCA occlusion, respectively, in which 11 T 2 -weighted coronal slices of the brain were taken using a multi slice spin echo sequence and parame ters that have been described in more detail elsewhere [repetition time 2,030 ms; echo time 60 ms; spatial reso lution in plane (156 f.lm) 2 ; slice thickness 1.35 mm; inter slice distance 1.5 mm; total measuring time 18 min (Alle grini Sauer et aI., 1993a) ].
Histology
For neuropathological examination of the brain, rats were perfusion fixed using a phosphate-buffered 4% for malin solution under deep Equithesin anesthesia [25 ml Vetanarcol (pentobarbital sodium 162 mg/ml, benzyl al cohol 20 mg/ml), 21.25 g chloral hydrate, 10.63 g MgS04, 198 ml propan-1 ,2-diol, and 50 ml ethanol in 500 ml dis tilled water; 3 mllkg i.p. (Foster et aI., 1988) ] immediately following the second MRI measurement. Brains were re moved, weighed, and stored in fixative at room temper ature for at least 2 days. Thereafter, they were embedded in Paraplast, and 5-f.lm-thick coronal serial sections were cut starting from the cranial end of the forebrain and con tinuing up to 7 mm caudally to cover the whole lesion. Single sections spaced 500 f.lm apart were stained with hematoxylin/eosin (HE; 15 sectionslbrain) for determina tion of brain atrophy, and every 1.5 mm one additional section was used for immunohistochemical demonstra tion of glial fibrillary acidic protein (GF AP; 5 sections/ brain).
Quantitative assessment of brain lesion
Quantitative morphometric evaluation of MRI slices or paraffin sections was performed using semiautomatic im age analysis systems (Bruker Aspect X32, Bruker, Karl sruhe, Germany, or Microscale TC, Digithurst, U.K., for MRI or histology, respectively). The extent of tissue damage as determined by MRI 2 days after MCA occlu sion was defined as the difference between the unlesioned areas of right and left hemispheres according to the method described by Swanson et al. (1990) , which cor rects for edema-induced brain swelling (Lin et aI., 1993) . Lesion volume was calculated based on the damaged area in each slice and the distance between slices. For deter mination of brain atrophy as assessed 28 days following MCA occlusion, the persisting area of the noninjured right and the injured left hemisphere was measured sep arately in all MRI pictures or HE sections, respectively, and hemispheric volumes were calculated using the same method as described for the determination of the acute lesion. Ischemia-induced brain atrophy was defined as the difference between the volumes of right and left brain hemisphere.
In addition, the extent of GF AP reaction was used for assessment of secondary damage in the thalamus. The size of the GF AP-positive area in that region was mea sured in one section (bregma -3.3) in both hemispheres and expressed as a percentage of the whole hemispheric thalamic area in that slice. A comparison was made be tween (a) the two hemispheres to investigate the influence of ischemia on GFAP formation and (b) untreated and CGP 40116-treated animals to examine the effect of drug treatment on that parameter.
Finally, a semiquantitative evaluation of the GF AP re action at the margin of the cortical lesion (bregma -0.2) as well as in the substantia nigra (bregma -6.0) was per formed using scores between 0 and 3 for no, minimal, moderate, or marked GFAP reaction, respectively.
Statistical comparisons
All values reported are means ± SD. Statistical com parisons between control and treatment groups were made using a one-way analysis of variance (ANOV A) for all calculations except for the comparison of the semi quantitative assessments where the Mann-Whitney V test was used. Comparisons for correlation were done by using the simple regression analysis model. All statistical calculations were made with the help of a software pack age (Stat View) for the Apple Macintosh. A p < 0.05 was regarded as being statistically significant.
RESULTS
On the first MRI scan 2 days after occlusion of the left MCA, damage of ipsilateral cortical and stri-atal tissue was seen in all animals ( Fig. 1A and B ). Treatment with 20 mg/kg CGP 40116 significantly reduced the volume of this early brain damage from 90.6 1-1 1 in untreated control rats to 50.3 1-1 1 in CGP
40116-treated animals (p < 0.01, ANOVA). The protective effect was limited to cortical tissue, while striatal damage remained unchanged ( Fig. 1A  and B ). This result confirmed the previously re-
FIG. 1. Comparison of representative T 2-weighted magnetic resonance images taken either 2 days (A and B) or 28 days (C and 0) after middle cerebral artery occlusion in rats with their matching hematoxylin/eosin-stained histological sections (E and F).
Pictures are from one rat that received no treatment (A, C, and E) and from a second animal that was treated with 20 mg/kg i.p.
CGP 40116 (8, D, and F). Note the pronounced reduction of early and late brain damage in the CGP 40116-treated rat.
ported protective effect of this competitive NMDA antagonist on acute brain damage induced by focal cerebral ischemia (Sauer et al., I993a) .
Evaluation of MRI images and HE sections taken 4 weeks after MCA occlusion showed that the isch emic insult had caused a marked loss of brain tissue (i.e., brain atrophy) that involved predominantly the cortex and partly the underlying structures ( Fig.  IC-F) . Brain atrophy was associated with the for mation o f a cyst-like cavity that was filled with ce rebrospinal fluid as indicated by the very high signal intensity of this area in the MRI scans ( Fig. IC-F) . Ipsilateral and sometimes contralateral ventricles were dilated. Quantitative assessment of the lesion as determined by MRI or histology revealed that CGP 40116-treated animals in comparison with un treated control rats had lost significantly less brain tissue over the 4-week period (Figs. 1 C-F and 2). The relative amount of protection was similar for both methods (57 and 64% for MRI and histology, respectively), and consequently quantitative com parison of the volume of lost tissue as determined by means of MRI and histology revealed a high cor relation between the procedures (correlation coef ficient r = 0.9, p < 0.0001, simple regression anal ysis) (Fig. 3A) . The absolute volume of brain atro phy was greater when measured by in vivo MRI (slope = 1.96) (Fig. 3A) . However, the relative amount of lost tissue expressed as a percentage of total left hemispheric volume was similar for both methods (slope = 1.01; data not shown). In addi- tion to these findings, there was a good correlation between the values for early damage as measured by MRI and the final size of the lesion determined by MRI (correlation coefficient r = 0. 73, p = 0.0001, simple regression analysis) ( Fig. 3B ) or his tology (correlation coefficient r = 0.8, p < 0.0001, simple regression analysis) (Fig. 3C) .
Occlusion of the left MCA resulted in an in creased GFAP reaction in some areas of the ipsilat eral hemisphere 28 days later (Fig. 4A-D) . This aug mented GFAP formation was detected mainly around the initial lesion ( Fig. 4A and B ), but also in brain regions that were not primarily affected by the ischemic insult (thalamus and substantia nigra) ( Fig.  4C-F) . Measurement of GFAP-positive tissue in the thalamus revealed an increased GFAP level in the left hemisphere for both groups of animals. The to tal amount of astrocytic gliosis in the left thalamus, however, was significantly reduced to 21.8 ± 13.8% in CGP 40116-treated rats compared with 38.4 ± 15.3% in untreated control animals (p < 0. 05, ANOV A) ( Fig. 5 ). Similar levels of GFAP reaction for both groups were found in the right thalamus (10.0 ± 7.7 and 10.1 ± 7.2% for treated and un treated rats, respectively) ( Fig. 5) . With use of a semiquantitative analysis, a significant difference between drug-treated and untreated animals could also be shown for the intensity of the astrocytic gliosis around the cortical lesion (p < 0.05, Mann Whitney V test) (Fig. 6) , while the amount of GF AP formation in the substantia nigra was similar for both groups (Fig. 4E and F) .
DISCUSSION
So far, the efficacy of neuroprotective drugs in focal cerebral ischemia has almost exclusively been evaluated during the acute phase of the ischemic insult and usually has focused on the determination of infarct volume after a short recovery period of several hours or 1-2 days. Only a few studies sys tematically examined how drug treatment influ enced chronic ischemic brain damage. Therefore, the objective of the present study was to evaluate whether the neuroprotective action of the compet itive NMDA antagonist CGP 40116 found in the acute phase after focal cerebral ischemia in rats (Sauer et aI., 1993a) could still be demonstrated during the chronic stage of infarction after a time of 28 days of recovery following the initial insult (Pers son et aI., 1989; Clark et aI., 1993) . By using in vivo MRI to measure cerebral infarction 2 days after the insult (Allegrini and Sauer, 1992; Sauer et aI., 1993a) , we had the opportunity to examine early and late brain damage in the same animals. Further- Vol, 15, No, 4, 1995 more, we tested whether MRI can be used for de termination of the final size of the ischemic lesion.
After a postischemic recovery period of 28 days, the resultant brain lesion was mainly characterized by two different types of damage: (a) a pronounced atrophy of brain tissue in the regions of the primary infarct (cortex and striatum) and (b) degeneration of neurons in areas of the ipsilateral hemisphere that are distant from the initial lesion (thalamus and sub stantia nigra). This outcome is in accordance with previous findings. Persson et ai. (1989) , Clark et ai. (1993) , and Hara et ai. (1993) described a significant reduction of the size of the ipsilateral hemisphere 1-3 months after MCA occlusion in rats with the formation of a fluid-filled cyst surrounded by a glial scar. This phenomenon is due to the removal of irreversibly damaged brain tissue by macrophages (Persson et aI., 1989; Chen et aI., 1993; Clark et aI., 1993) . Secondary damage in ipsilateral thalamus and substantia nigra brain areas, which are not af fected during the early phase of infarction, is also a common finding after a focal ischemic insult in an imals (Fujie et aI., 1990; Iizuka et aI., 1990; Naga sawa and Kogure, 1990; Tamura et aI., 1990; Hara et aI. , 1993; Morioka et aI., 1993) and has been de tected in humans suffering from stroke (Tamura et aI. , 1991; Nakane et aI., 1992) . The cause of the thalamic injury seems to be retrograde neurodegen eration induced by damage of thalamocortical fibers in the infarcted cortex (for discussion see Kataoka et aI., 1989; Iizuka et aI., 1990) , while the loss of GABAergic inhibition due to destruction of the stri atum, leading to increased neuronal excitation, may be responsible for the degeneration of neurons in the substantia nigra (Tamura et aI., 1990) . The idea of an association between cortical and striatal injury and secondary neuronal damage in thalamus and substantia nigra is also supported by the finding of Hara et ai. (1993) , They showed a significant corre lation between the extent of atrophy in cortex and thalamus as well as between the damage in striatum and substantia nigra.
In our study the amount of lost brain tissue could be quantified by in vivo MRI and conventional his tological methods equally well. The absolute vol ume of atrophy as determined by MRI was about two times greater than the lesion measured histo logically. This result is most probably due to shrink age of the brains during the process of histological preparation since the relative amount of brain atro phy was virtually identical for both procedures. The same relation between absolute and relative s ize of the cerebral lesion as evaluated by the two methods has been found if damage was measured during the acute phase of cerebral ischemia 2 days after MCA ... occlusion in rats (Sauer et aI., 1993a) . Comparison of lesion volume as measured 2 days after induction of the ischemic insult with brain atrophy deter mined 26 days later by either MRI or histology re vealed that the amount of injured tissue after 2 days was a good predictor for the extent of final brain damage. This result is similar to a previous study using a mouse MCA occlusion model (Weber et aI., 1993) .
Our results indicate that a single intraperitoneal bolus injection of 20 mg/kg CGP 40116 permanently protected neuronal tissue from the consequences of a focal cerebral ischemia. While previous studies have shown that competitive NMDA antagonists are potent neuroprotectants during the acute phase of infarction (Bullock et al., 1990; Simon and Shiraishi, 1990; Sauer et aI., 1993a) , this is the first time that such an effect has been demonstrated for this class of compound following a prolonged recov ery period after the ischemic insult. CGP 40116 ef ficiently prevented brain atrophy and also resulted in a less extensive astrocytic gliosis in the border zone of the ischemic lesion, indicating that reduc tion in tissue loss was not due to a larger glial scar but to the preservation of intact neurons. Protection J Cereb Blood Flow Metab, Vol. 15, No.4, 1995 was, however, not limited to the primary injury, but was also present in the thalamus, an area of second ary neurodegeneration, where CGP 40116 signifi cantly reduced the amount of reactive gliosis. This effect is most likely directly linked to the preserva tion of cortical tissue (Kataoka et aI., 1989; Iizuka et aI., 1990; Hara et aI., 1993; see previously) , while the failure of CGP 40116 to influence GFAP reac tion in the substantia nigra is presumably due to the inability of this compound to protect against isch emic neuronal damage in the striatum in this animal model.
A positive action of two other drugs, the nonse lective glutamate antagonist 6,7-dinitroquinoxaline-2,3-dione and the calcium antagonist 1-[bis(4fluoropheny l)meth yl] -4-(2,3 ,4-trimethoxy benzyl)piperazine dihydrochloride (KB-2796), on chronic infarction 1 month after focal cerebral isch emia has been reported (Hara et aI., 1993) . They report that both compounds significantly reduced brain atrophy induced by transient (1 h) MCA oc clusion in rats. Similar to our experiment, protec tion was not limited to the primary ischemic lesion but occurred in remote brain regions. A positive effect on late brain damage has also been described for the noncompetitive NMDA channel blocker MK-801, which reduced the volume of brain atro phy 2-3 months after MCA occlusion in mice (We ber et aI., 1993) . In contrast to those findings, MK-801, at doses that reduced acute brain damage, failed to influence cerebral infarction after pro- longed recovery following either permanent MCA occlusion in rats (Persson et al., 1992) or transient (2 h) MCA occlusion in cats (Dezsi et al., 1994) . In the cat model, however, MK-801 significantly in creased the number of surviving animals, and the authors speculate that MK-801 might promote the survival of animals with larger infarcts (Dezsi et al., 1994) . The exact reason for the discrepancy be tween the different studies is currently unclear. A possible explanation could be the fact that CGP 40116 and MK-801 have different pharmacokinetic properties. Following systemic administration in rats, MK-801 has a brain half-life of -2 h (Vezzani et al., 1989) . In contrast, comparable levels of CGP 40116 have been found in rat brain 2 or 24 h after a single per os administration, indicating a longer brain half-life of this compound when compared with MK 801 (H. SchUtz et aI., unpublished). A long brain half-life has also been reported for the com petitive NMDA antagonists 2-amino-4-propyl-5phosphono-3-pentenoic acid (CGP 39653, a struc tural analogue of CGP 40116) (Massieu et al., 1993) and (± )-cis-4-(phosphonomethyl)-2-piperidine car boxylic acid (CGS 19755, selfotel) (Yoon et al., 1993) . As a consequence of their slower elimination from the brain following a single bolus administra tion, competitive NMDA antagonists would be able to block the receptor for a longer time period than MK-801, and this may be necessary to achieve long lasting neuroprotection after focal cerebral isch emia. Additional experiments, preferably with side by-side comparison of several NMDA antagonists and/or treatment protocols (i.e., single bolus injec tion versus multiple bolus injection or constant in fusion) and subsequent evaluation of brain damage at several time points after induction of the isch emic insult, are needed to further elucidate this is sue.
In conclusion, the results of the present study demonstrate that (a) the competitive NMDA antag onist CGP 40116 protects brain tissue from the acute and prolonged consequences of focal isch emia in a rat model for human stroke and (b) in vivo MRI is a useful method to examine the evolution of ischemic brain damage in small animals.
